Last reviewed · How we verify
Egg-based Quadrivalent Influenza Vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Egg-based Quadrivalent Influenza Vaccine (Egg-based Quadrivalent Influenza Vaccine) — ModernaTX, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Egg-based Quadrivalent Influenza Vaccine TARGET | Egg-based Quadrivalent Influenza Vaccine | ModernaTX, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Egg-based Quadrivalent Influenza Vaccine CI watch — RSS
- Egg-based Quadrivalent Influenza Vaccine CI watch — Atom
- Egg-based Quadrivalent Influenza Vaccine CI watch — JSON
- Egg-based Quadrivalent Influenza Vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Egg-based Quadrivalent Influenza Vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/egg-based-quadrivalent-influenza-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab